Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 258 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2923 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
13 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CLOPIDOGREL | 300MG | TABLET | Anticipated shortage | 2025-11-27 | 2025-11-27 | 272769 |
| TEVA-CLOXACILLIN | 125MG | GRANULES FOR SOLUTION | Resolved | 2017-08-21 | 2017-09-19 | 19937 |
| TEVA-CLOXACILLIN | 125MG | GRANULES FOR SOLUTION | Resolved | 2021-01-07 | 2021-02-25 | 131063 |
| TEVA-CLOXACILLIN | 250MG | CAPSULE | Resolved | 2021-10-28 | 2021-12-02 | 148424 |
| TEVA-CLOXACILLIN | 250MG | CAPSULE | Resolved | 2022-09-07 | 2022-09-23 | 168729 |
| TEVA-CLOXACILLIN | 125MG | GRANULES FOR SOLUTION | Resolved | 2023-06-08 | 2023-07-05 | 194054 |
| TEVA-CLOXACILLIN | 125MG | GRANULES FOR SOLUTION | Resolved | 2023-06-19 | 2023-10-03 | 195518 |
| TEVA-CLOXACILLIN | 500MG | CAPSULE | Resolved | 2023-07-13 | 2023-10-03 | 198587 |
| TEVA-CLOXACILLIN | 125MG | GRANULES FOR SOLUTION | Resolved | 2025-07-03 | 2025-10-23 | 261779 |
| TEVA-CODEINE | 30MG | TABLET | Resolved | 2020-03-26 | 2020-04-02 | 109589 |
| TEVA-CODEINE | 15MG | TABLET | Resolved | 2020-06-18 | 2020-07-09 | 118250 |
| TEVA-CODEINE | 30MG | TABLET | Resolved | 2020-11-27 | 2020-12-17 | 129039 |
| TEVA-CODEINE | 30MG | TABLET | Resolved | 2021-03-25 | 2021-06-03 | 136295 |
| TEVA-CODEINE | 30MG | TABLET | Resolved | 2021-08-05 | 2021-09-30 | 143728 |
| TEVA-CODEINE | 30MG | TABLET | Resolved | 2021-11-04 | 2022-03-09 | 148838 |
| TEVA-CODEINE | 15MG | TABLET | Resolved | 2022-03-24 | 2022-05-19 | 157253 |
| TEVA-CODEINE | 30MG | TABLET | Resolved | 2022-07-25 | 2022-12-22 | 165436 |
| TEVA-CODEINE | 15MG | TABLET | Resolved | 2022-07-25 | 2022-12-22 | 165444 |
| TEVA-CODEINE | 15MG | TABLET | Resolved | 2023-04-27 | 2023-06-09 | 190701 |
| TEVA-CODEINE | 30MG | TABLET | Resolved | 2025-05-22 | 2025-06-05 | 258115 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |